Immune Regulation and DynPort partner to advance IRL-201104 for COVID-19-related ARDS July 7, 2020 No Comments
CSL Behring initiates phase II study of CSL-312 for respiratory distress in patients with COVID-19 July 7, 2020 No Comments
Clinical study of desidustat for the management of COVID-19 approved in Mexico July 7, 2020 No Comments
FDA clears initiation of phase III trial of siltuximab for COVID-19-associated ARDS July 2, 2020 No Comments
FDA clears first clinical trial of M-5049 in patients with COVID-19 pneumonia June 26, 2020 No Comments
First patient dosed in phase II study of TD-0903 for the treatment of ALI caused by COVID-19 June 26, 2020 No Comments
RSS